改良手术联合激光治疗新生血管性青光眼合并玻璃体积血  

Improved Surgery Combined with Laser Beam for Neovascular Glaucoma Combined with Vitreous Hemorrhage

作　　者：刘凌[1] 石霞[1] 刘维慈 

机构地区：[1]浙江省衢州市人民医院眼科,浙江衢州324000 [2]浙江省龙游县人民医院眼科,浙江龙游324400

出　　处：《中国慢性病预防与控制》2009年第4期368-369,共2页Chinese Journal of Prevention and Control of Chronic Diseases

摘　　要：目的评价改良手术联合激光治疗新生血管性青光眼合并玻璃体积血的疗效与安全性。方法新生血管性青光眼合并玻璃体积血21例,22眼。根据分期分别采用改良玻璃体切割术、改良小梁切除术联合激光治疗;改良玻璃体切割术联合激光等两种方法治疗。治疗后随访3～36个月。结果显效10眼(45.5%),有效8眼(36.4%),无效4眼(18.2%)。术前平均眼压(32.24±8.32)mmHg,术后平均眼压(27.28±6.31)mmHg,两者比较差别有统计学意义(P<0.05)。玻璃体积血完全消退12眼(54.5%),视力提高7眼(31.8%),4眼(18.2%)眼压失控行睫状体冷冻治疗。结论改良手术联合激光治疗新生血管性青光眼合并玻璃体积血在一定程度上能阻止疾病发展,保留一定视力,较为安全。Objective To evaluate the efficacy and safety of improved surgery combined with laser beam for neovascular glaucoma combined with vitreous hemorrhage. Methods 21 cases （22 eyes） with neovascular glaucoma combined with vitreous hemorrhage were operated on with improved vitreoretinal surgery, improved trabeculectomy combined with laser, or improved vetreoreninal surgery combined with laser according to the stage of disease, respectively. Results The follow-up ranged from 3 to 36 months after surgery. 10 eyes were remarkably effective （45.5%）, 8 eyes were effective ,4 eyes were no effective. Mean intraocular pressure were 27.28±6.31 mm Hg before surgery and significantly different （P〈0.05） as compared with that after surgery （27.28±6.31 mm Hg）. 12 eyes （54.5%） with vitreous hemorrhage healed completely. Eyesight of 7 eyes （31.8%） improved. 4 eyes＇s intraocular pressure was out of control and were taken cyclocryotherapy. Conclusion Improved surgery combined with laser can prevent disease development, remain a certain vision, and it is a safe method for neovascular glaucoma combined with vitreous hemorrhage.

关 键 词：小梁切除术 激光 青光眼 新生血管性 玻璃体积血 玻璃体切割术 

分 类 号：R775[医药卫生—眼科]